Advertisement

Nephrotoxicity of Fumaric Acid Monoethylester (FA ME)

  • M. Hohenegger
  • M. Vermes
  • A. Sadjak
  • G. Egger
  • S. Supanz
  • U. Erhart
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)

Abstract

Fumaric acid monoethylester (FA ME) is used as a therapeutic agent against psoriasis. As there exists some clinical evidence for nephro — toxicity (2,9) the present investigations were performed.

Keywords

Glomerular Filtration Rate Lactate Production Fumaric Acid Water Deprivation Kidney Cortex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal.Biochem. 72, 248–254, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Dubiel W., Happle R.: Behandlungsversuch mit Fumarsäuremonoäthyl – ester bei Psoriasis vulgaris. Z.Hautkrankh. 47, 545–550, 1972.Google Scholar
  3. 3.
    Hagedorn M., Kalkoff K.W., Kiefer G., Baron D., Hug J., Petres J.: Fumarsäuremonoäthylester: Wirkung auf DNA Synthese und erste tier – experimentelle Befunde. Arch.Derm.Res. 254, 67–73, 1975.CrossRefGoogle Scholar
  4. 4.
    Hohenegger M., Vermes M., Esposito R., Giordano C.: Effect of some uremic toxins on oxygen consumption of rats in vivo and in vitro. Nephron 48, 154–158, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Holzer F., Hohenegger M.: Sodium and potassium adaptation in the conscious rat. Pharmacology l0, 76–81, 1973.CrossRefGoogle Scholar
  6. 6.
    Hörl W., Echsel H., Hohenegger M.: The key role of sex dependency on kidney citrate metabolism in the rat. Res.Exp.Med. 185, 69–75, 1985.CrossRefGoogle Scholar
  7. 7.
    Korsatko W., Sadjak A., Gall P., Supanz S.: Entwicklung kombinierter Inulin – PAH Retardimplantationstabletten zur Bestimmung der Clearance an wachen Ratten. Die Pharmazie 43, 324–327, 1987.Google Scholar
  8. 8.
    Om P., Hohenegger M.: Energy metabolism in acute uremic rats. Nephron 25, 249–253, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Raab W.: Psoriasis Behandlung mit Fumarsäure und Fumarsäureestem. Z.Hautkrankh. 59, 671–679, 1984.Google Scholar
  10. 10.
    Renschier D.: Die enzymatischen Methoden zur Bestimmung von Inulin. Klin.Wschr. 41, 615–618, 1961.CrossRefGoogle Scholar
  11. 11.
    Ruiz-Guinazu A., Pehling G., Rumrich G., Ullrich K.J.: Glucose- un Milchsäurekonzentration an der Spitze des vasculären Gegenstrom systems im Nierenmark. Pflügers Arch.Ges.Physiol. 274, 311–317, 1961.CrossRefGoogle Scholar
  12. 12.
    Sadjak A., Egger G., Kink E., Korsatko W.: Functional and morphological changes in the rat kidney after long term adrenaline application. Exp.Pathol. 25, 27–33, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • M. Hohenegger
    • 1
  • M. Vermes
    • 1
  • A. Sadjak
    • 2
  • G. Egger
    • 2
  • S. Supanz
    • 2
  • U. Erhart
    • 2
  1. 1.Institute of General and Experimental PathologyUniversity of ViennaAustria
  2. 2.Institute of Functional PathologyUniversity of GrazAustria

Personalised recommendations